- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有3家主力机构披露2022-12-31报告期持股数据，持仓量总计500.30万股，占流通A股1.26%
- 波段诊断：
-
技术面诊股
诊断结果：3.8技术面打败了38%的股票
技术面评分前10的股票
近期的平均成本为29.33元。
平均成本
近期的平均成本为29.33元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"29.33","date":1675325707,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2023.02.03","stock":"0.48","trade":null,"ind":"-0.63"},{"date":"2023.02.02","stock":"1.17","trade":null,"ind":"-0.22"},{"date":"2023.02.01","stock":"1.29","trade":null,"ind":"1.31"},{"date":"2023.01.31","stock":"-2.44","trade":null,"ind":"-0.80"},{"date":"2023.01.30","stock":"-0.77","trade":null,"ind":"0.98"},{"date":"2023.01.20","stock":"-1.53","trade":null,"ind":"0.57"},{"date":"2023.01.19","stock":"5.49","trade":null,"ind":"0.87"},{"date":"2023.01.18","stock":"-0.80","trade":null,"ind":"0.09"},{"date":"2023.01.17","stock":"0.91","trade":null,"ind":"0.13"},{"date":"2023.01.16","stock":"-0.63","trade":null,"ind":"1.58"},{"date":"2023.01.13","stock":"3.75","trade":null,"ind":"1.19"},{"date":"2023.01.12","stock":"-1.21","trade":null,"ind":"0.23"},{"date":"2023.01.11","stock":"0.11","trade":null,"ind":"-0.59"},{"date":"2023.01.10","stock":"4.48","trade":null,"ind":"0.49"},{"date":"2023.01.09","stock":"0.04","trade":null,"ind":"0.73"},{"date":"2023.01.06","stock":"-1.33","trade":null,"ind":"0.32"},{"date":"2023.01.05","stock":"-1.59","trade":null,"ind":"2.13"},{"date":"2023.01.04","stock":"1.85","trade":null,"ind":"-0.20"},{"date":"2023.01.03","stock":"2.46","trade":null,"ind":"0.92"},{"date":"2022.12.30","stock":"-0.86","trade":null,"ind":"0.18"},{"date":"2022.12.29","stock":"4.46","trade":null,"ind":"-0.13"}]
艾德生物,深证成指,医疗器械指数
压力支撑
该股压力位为29.23元，支撑位为28.84元。
[{"text":"\u538b\u529b\u4f4d","value":"29.23","date":1675353600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"28.84","date":1675353600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.8资金面打败了52%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：02月03日 20:30
| 机构今日流向(万元) | -690.29 | 机构5日流向(万元) | -1689.43 |
| 机构10日流向(万元) | -1623.59 | 机构20日流向(万元) | -2512.79 |
机构持仓
2022-12-31 与 2022-06-30 相比，主力机构持仓量减少27521.13万股，其中基金净增仓1家，主力净减仓121家，暂未发现中长期投资价值。
截止2022-12-31，共3家主力机构（基金3家），持仓量总计500.3万股，占流通A股1.26%
其中，基金持仓与2022-06-30相比：
增仓：2家 ，增持 20.25万股
减仓：1家 ，减持 55.82万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：121家 ，原持有27485.56万股
其中，基金持仓与2022-06-30相比：
增仓：2家 ，增持 20.25万股
减仓：1家 ，减持 55.82万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：121家 ，原持有27485.56万股
消息面诊股
诊断结果：5.5消息面打败了45%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 艾德生物：2月2日获融资买入417.52万元，占当
2023-02-03 - 沪深股通|艾德生物2月2日获外资买入0.09%股份
2023-02-03 - 艾德生物：检测人群微卫星不稳定性的生物标志物组及其
2023-02-02 - 艾德生物累计回购353.12万股 耗资9997.0
2023-02-02 - 艾德生物：2月1日获融资买入470.28万元，占当
2023-02-02 - 沪深股通|艾德生物2月1日获外资卖出0.05%股份
2023-02-02 - 延续完美！艾德医学检验实验室再次零缺陷通过CAP复
2023-02-01 - 艾德生物：1月31日融券卖出金额34.21万元，占
2023-02-01 - 沪深股通|艾德生物1月31日获外资卖出6643.0
2023-02-01 - 艾德生物：1月30日融券卖出金额62.77万元，占
2023-01-31
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2022-12-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2022-07-30 |
| 一般消息 | 股东大会 | 临时股东大会 | 2022-06-03 |
| 利好 | 分红转增 | 10转8股派2.3元(含税) | 2022-04-12 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了0%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2023.02.03","price":"-0.63","value":null},{"date":"2023.02.02","price":"-0.22","value":null},{"date":"2023.02.01","price":"1.31","value":null},{"date":"2023.01.31","price":"-0.80","value":null},{"date":"2023.01.30","price":"0.98","value":null},{"date":"2023.01.20","price":"0.57","value":null},{"date":"2023.01.19","price":"0.87","value":null},{"date":"2023.01.18","price":"0.09","value":null},{"date":"2023.01.17","price":"0.13","value":null},{"date":"2023.01.16","price":"1.58","value":null},{"date":"2023.01.13","price":"1.19","value":null},{"date":"2023.01.12","price":"0.23","value":null},{"date":"2023.01.11","price":"-0.59","value":null},{"date":"2023.01.10","price":"0.49","value":null},{"date":"2023.01.09","price":"0.73","value":null},{"date":"2023.01.06","price":"0.32","value":null},{"date":"2023.01.05","price":"2.13","value":null},{"date":"2023.01.04","price":"-0.20","value":null},{"date":"2023.01.03","price":"0.92","value":null},{"date":"2022.12.30","price":"0.18","value":null},{"date":"2022.12.29","price":"-0.13","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 睿昂基因 | 46.95% | 25.11% | 5.0分 |
| 2 | 赛科希德 | 44.19% | 2.24% | 4.6分 |
| 3 | 科美诊断 | 36.29% | 6.09% | 4.9分 |
| 4 | 康为世纪 | 33.67% | 14.80% | 5.0分 |
| 5 | 春立医疗 | 31.15% | -2.56% | 4.2分 |
| 6 | 华兰股份 | 30.67% | 12.43% | 4.4分 |
| 8 | 伟思医疗 | 27.41% | 12.34% | 4.2分 |
| 10 | 普门科技 | 24.54% | -4.51% | 4.3分 |
| 12 | 三友医疗 | 21.74% | 5.42% | 4.7分 |
| 14 | 新华医疗 | 20.56% | 1.24% | 4.5分 |
| 16 | 福瑞股份 | 19.04% | 0.03% | 4.2分 |
| 18 | 安必平 | 18.07% | 4.75% | 4.6分 |
| 20 | 正海生物 | 17.14% | -0.93% | 4.5分 |
| 22 | 奥精医疗 | 16.02% | 6.64% | 4.9分 |
| 24 | 迪瑞医疗 | 15.84% | 7.62% | 4.7分 |
| 26 | *ST和佳 | 14.56% | 0.00% | 3.6分 |
| 28 | 中红医疗 | 13.53% | 1.90% | 3.6分 |
| 30 | 祥生医疗 | 13.07% | -0.34% | 4.3分 |
| 32 | 麦澜德 | 12.48% | 3.42% | 3.9分 |
| 34 | 海尔生物 | 12.32% | -6.08% | 5.0分 |
| 36 | 澳华内镜 | 12.15% | -3.49% | 3.3分 |
| 38 | 万东医疗 | 11.59% | 5.93% | 4.7分 |
| 40 | 艾德生物 | 10.94% | -0.34% | 4.2分 |
| 42 | 大博医疗 | 10.61% | 3.90% | 4.1分 |
| 44 | 爱威科技 | 10.32% | 3.82% | 4.8分 |
| 46 | 中源协和 | 10.11% | 3.14% | 4.6分 |
| 48 | 美好医疗 | 9.90% | 3.82% | 4.2分 |
| 50 | 戴维医疗 | 9.15% | 0.35% | 4.2分 |
| 52 | 健帆生物 | 8.84% | -0.76% | 3.9分 |
| 54 | 透景生命 | 8.63% | 1.61% | 4.1分 |
| 56 | 安图生物 | 8.22% | 2.38% | 4.1分 |
| 58 | 三鑫医疗 | 7.43% | 1.43% | 4.3分 |
| 60 | 迈克生物 | 7.20% | 1.13% | 3.8分 |
| 62 | 东星医疗 | 6.38% | 3.44% | 4.2分 |
| 64 | 安旭生物 | 6.13% | 0.98% | 4.7分 |
| 66 | 亚辉龙 | 5.95% | 3.06% | 5.4分 |
| 68 | 正川股份 | 5.84% | 2.89% | 4.1分 |
| 70 | 冠昊生物 | 5.40% | 4.28% | 4.1分 |
| 72 | 硕世生物 | 4.90% | 1.15% | 5.3分 |
| 74 | 利德曼 | 4.16% | 1.01% | 4.0分 |
| 76 | 三诺生物 | 3.72% | -5.23% | 4.8分 |
| 78 | 怡和嘉业 | 3.47% | 6.02% | 5.0分 |
| 80 | 南卫股份 | 3.35% | 4.68% | 5.0分 |
| 82 | 奥泰生物 | 3.29% | 2.39% | 4.9分 |
| 84 | 奥美医疗 | 2.39% | -0.56% | 4.4分 |
| 86 | 海泰新光 | 2.22% | 1.25% | 4.3分 |
| 88 | 明德生物 | 1.90% | 2.30% | 4.8分 |
| 90 | 昊海生科 | 1.88% | -5.60% | 3.7分 |
| 92 | 九安医疗 | 1.82% | 3.67% | 4.9分 |
| 94 | 爱博医疗 | 1.58% | -0.33% | 4.4分 |
| 96 | 之江生物 | 1.50% | -0.26% | 3.9分 |
| 98 | 万孚生物 | 1.30% | 2.19% | 4.3分 |
| 100 | 博拓生物 | 0.88% | 1.13% | 4.1分 |
| 102 | 振德医疗 | 0.39% | -0.03% | 4.1分 |
| 104 | 拱东医疗 | -0.69% | -0.08% | 3.3分 |
| 106 | 热景生物 | -2.20% | 1.18% | 4.4分 |
| 108 | 可孚医疗 | -2.91% | -1.62% | 3.5分 |
| 110 | 微电生理 | -3.19% | 0.80% | 3.9分 |
| 112 | 爱朋医疗 | -5.23% | 1.06% | 4.1分 |
| 114 | 宝莱特 | -8.74% | 2.40% | 3.8分 |
| 116 | 康泰医学 | -18.19% | 1.20% | 3.5分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2022-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 27/226 ， 7/226。
[{"date":"2022-09-30","value":"15.75","vol":"13.08"},{"date":"2022-06-30","value":"6.48","vol":"9.92"},{"date":"2022-03-31","value":"3.87","vol":"6.20"},{"date":"2021-12-31","value":"19.22","vol":"17.90"},{"date":"2021-09-30","value":"14.55","vol":"14.91"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
15.75 | 6.48 | 3.87 | 19.22 | 14.55 |
| 行业(%) | 13.08 | 9.92 | 6.20 | 17.90 | 14.91 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2022-09-30","value":"83.24","vol":"55.05"},{"date":"2022-06-30","value":"83.14","vol":"55.18"},{"date":"2022-03-31","value":"83.16","vol":"53.77"},{"date":"2021-12-31","value":"84.38","vol":"58.04"},{"date":"2021-09-30","value":"83.93","vol":"58.95"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
83.24 | 83.14 | 83.16 | 84.38 | 83.93 |
| 行业(%) | 55.05 | 55.18 | 53.77 | 58.04 | 58.95 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 92/226 ， 32/226。
[{"date":"2022-09-30","value":"-7.20","vol":"51.29"},{"date":"2022-06-30","value":"-1.62","vol":"65.88"},{"date":"2022-03-31","value":"18.60","vol":"111.12"},{"date":"2021-12-31","value":"25.90","vol":"31.93"},{"date":"2021-09-30","value":"33.41","vol":"53.39"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-7.20 | -1.62 | 18.60 | 25.90 | 33.41 |
| 行业(%) | 51.29 | 65.88 | 111.12 | 31.93 | 53.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2022-09-30","value":"26.96","vol":"222.62"},{"date":"2022-06-30","value":"-19.79","vol":"255.93"},{"date":"2022-03-31","value":"23.46","vol":"379.07"},{"date":"2021-12-31","value":"32.86","vol":"17.75"},{"date":"2021-09-30","value":"39.98","vol":"290.40"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
26.96 | -19.79 | 23.46 | 32.86 | 39.98 |
| 行业(%) | 222.62 | 255.93 | 379.07 | 17.75 | 290.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 44/226 ， 34/226。
[{"date":"2022-09-30","value":"0.38","vol":"0.40"},{"date":"2022-06-30","value":"0.26","vol":"0.29"},{"date":"2022-03-31","value":"0.13","vol":"0.16"},{"date":"2021-12-31","value":"0.65","vol":"0.58"},{"date":"2021-09-30","value":"0.47","vol":"0.42"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.38 | 0.26 | 0.13 | 0.65 | 0.47 |
| 行业(次) | 0.40 | 0.29 | 0.16 | 0.58 | 0.42 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2022-09-30","value":"2.58","vol":"2.18"},{"date":"2022-06-30","value":"1.69","vol":"1.48"},{"date":"2022-03-31","value":"1.11","vol":"0.78"},{"date":"2021-12-31","value":"5.34","vol":"2.98"},{"date":"2021-09-30","value":"3.63","vol":"1.85"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.58 | 1.69 | 1.11 | 5.34 | 3.63 |
| 行业(次) | 2.18 | 1.48 | 0.78 | 2.98 | 1.85 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2022-09-30","value":"36.40","vol":"17.18"},{"date":"2022-06-30","value":"22.80","vol":"18.87"},{"date":"2022-03-31","value":"13.57","vol":"4.06"},{"date":"2021-12-31","value":"16.17","vol":"38.96"},{"date":"2021-09-30","value":"12.71","vol":"19.87"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 36.40 | 22.80 | 13.57 | 16.17 | 12.71 |
| 行业 | 17.18 | 18.87 | 4.06 | 38.96 | 19.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2022-09-30","value":"","vol":"0.02"},{"date":"2022-06-30","value":"2.14","vol":"3.12"},{"date":"2022-03-31","value":"","vol":"0.09"},{"date":"2021-12-31","value":"1.88","vol":"4.23"},{"date":"2021-09-30","value":"","vol":"0.21"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.14 | - | 1.88 | - |
| 行业 | 0.02 | 3.12 | 0.09 | 4.23 | 0.21 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 107/226 ， 107/226。
[{"date":"2022-09-30","value":"14.56","vol":"6.05"},{"date":"2022-06-30","value":"14.37","vol":"5.52"},{"date":"2022-03-31","value":"11.01","vol":"5.94"},{"date":"2021-12-31","value":"8.85","vol":"5.54"},{"date":"2021-09-30","value":"10.31","vol":"5.78"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
14.56 | 14.37 | 11.01 | 8.85 | 10.31 |
| 行业 | 6.05 | 5.52 | 5.94 | 5.54 | 5.78 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2022-09-30","value":"13.96","vol":"5.07"},{"date":"2022-06-30","value":"13.73","vol":"4.62"},{"date":"2022-03-31","value":"10.64","vol":"4.98"},{"date":"2021-12-31","value":"8.53","vol":"4.72"},{"date":"2021-09-30","value":"9.90","vol":"4.81"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
13.96 | 13.73 | 10.64 | 8.53 | 9.90 |
| 行业 | 5.07 | 4.62 | 4.98 | 4.72 | 4.81 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 99/226 ， 100/226。
[{"date":"2022-09-30","value":"9.18","vol":"21.60"},{"date":"2022-06-30","value":"9.65","vol":"22.82"},{"date":"2022-03-31","value":"8.09","vol":"22.32"},{"date":"2021-12-31","value":"9.89","vol":"23.46"},{"date":"2021-09-30","value":"8.68","vol":"21.12"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
9.18 | 9.65 | 8.09 | 9.89 | 8.68 |
| 行业(%) | 21.60 | 22.82 | 22.32 | 23.46 | 21.12 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2022-09-30","value":"0.10","vol":"0.37"},{"date":"2022-06-30","value":"0.11","vol":"0.39"},{"date":"2022-03-31","value":"0.09","vol":"0.39"},{"date":"2021-12-31","value":"0.11","vol":"0.41"},{"date":"2021-09-30","value":"0.10","vol":"0.34"}]
| 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.10 | 0.11 | 0.09 | 0.11 | 0.10 |
| 行业(%) | 0.37 | 0.39 | 0.39 | 0.41 | 0.34 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2022年每股收益与前一年相同，长期投资价值一般。
[{"date":"2018","yellowRectValue":"1.27","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"1.35","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"1.80","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"2.40","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.91","blueLineValue":"0.73","type":"YC"}]